Ajooni Biotech Limited

NSEI:AJOONI Stock Report

Market Cap: ₹1.2b

Ajooni Biotech Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Gursimran Singh

Chief executive officer

₹1.2m

Total compensation

CEO salary percentage100.0%
CEO tenure4.3yrs
CEO ownershipn/a
Management average tenure4.8yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

Ajooni Biotech (NSE:AJOONI) May Have Issues Allocating Its Capital

Oct 11
Ajooni Biotech (NSE:AJOONI) May Have Issues Allocating Its Capital

Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Sep 04
Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up

Jul 12
Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up

Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower

Mar 20
Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower

We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

Nov 10
We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

Jul 13
We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late

Feb 16
If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late

Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Feb 14
Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?

Dec 24
Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?

CEO Compensation Analysis

How has Gursimran Singh's remuneration changed compared to Ajooni Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹26m

Jun 30 2024n/an/a

₹22m

Mar 31 2024₹1m₹1m

₹22m

Dec 31 2023n/an/a

₹18m

Sep 30 2023n/an/a

₹15m

Jun 30 2023n/an/a

₹12m

Mar 31 2023₹1m₹1m

₹11m

Dec 31 2022n/an/a

₹5m

Sep 30 2022n/an/a

₹9m

Jun 30 2022n/an/a

₹11m

Mar 31 2022₹2m₹2m

₹10m

Dec 31 2021n/an/a

₹11m

Sep 30 2021n/an/a

₹7m

Jun 30 2021n/an/a

₹4m

Mar 31 2021₹540k₹540k

₹4m

Compensation vs Market: Gursimran's total compensation ($USD14.10K) is below average for companies of similar size in the Indian market ($USD42.37K).

Compensation vs Earnings: Gursimran's compensation has been consistent with company performance over the past year.

CEO

Gursimran Singh (36 yo)

4.3yrs

Tenure

₹1,200,000

Compensation

Mr. Gursimran Singh had been the Chief Financial Officer of Prism Medico and Pharmacy Limited December 4, 2017 until May 16, 2023 and served as its Executive Director from April 01, 2017 to October 5, 2019...

Leadership Team

NamePositionTenureCompensationOwnership
Jasjot Singh
Chairman7.3yrs₹3.00m13.96%
₹ 170.8m
Gursimran Singh
CEO & Whole Time Directorno data₹1.20mno data
Partek Singh
Executive & Non-Independent Director7.5yrs₹300.00kno data
Swati Vijan
Company Secretary & Compliance Officer4.8yrs₹571.00kno data

4.8yrs

Average Tenure

36yo

Average Age

Experienced Management: AJOONI's management team is considered experienced (4.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jasjot Singh
Chairman7.3yrs₹3.00m13.96%
₹ 170.8m
Gursimran Singh
CEO & Whole Time Director4.3yrs₹1.20mno data
Partek Singh
Executive & Non-Independent Director7.5yrs₹300.00kno data
Simmi Chhabra
Independent Non-Executive Woman Director7.3yrs₹30.00k0.037%
₹ 449.9k
Imteshwar Bhatia
Independent Non-Executive Director7.3yrs₹30.00kno data
Ramandeep Singh
Independent Non-Executive Director7.3yrs₹30.00kno data

7.3yrs

Average Tenure

36.5yo

Average Age

Experienced Board: AJOONI's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:46
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ajooni Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution